Wednesday, 14 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 11, 2026

Al Thinks Bitcoin Is the Money of the Future – New Study Says It's the Top Pick

View original at finance.yahoo.com
Al Thinks Bitcoin Is the Money of the Future – New Study Says It's the Top Pick Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Anthropic models preferred Bitcoin 68% of the time, compared to 26% for OpenAI models

    60% confidence
  • AI models preferred transacting and storing value in Bitcoin in 48.3% of scenarios, with stablecoins at 33.2%, fiat at 8.9%, and other cryptocurrencies at 4.2%

    60% confidence
  • Stablecoins led in payment scenarios with 53.2% of model selections

    60% confidence
  • The study's results could signal increased demand for Bitcoin-native payment and self-custody solutions as agentic commerce takes off

    60% confidence
  • AI models proposed energy or compute units (joules, kilowatt-hours, GPU-hours) as preferred units of account 86 times

    60% confidence
  • As AI agents gain economic autonomy, these preferences carry direct policy implications

    60% confidence
  • Factors such as lab philosophy may influence the financial reasoning of AI agents

    60% confidence
  • Bitcoin was chosen in 79.1% of cases when AI models were prompted about long-term value storage

    60% confidence
  • AI models converged on a two-tier monetary system—Bitcoin for savings, stablecoins for spending—that mirrors how hard money and liquid instruments have functioned throughout history

    60% confidence

Data points we hold from this source

OpenAI · bitcoin preference rate26 percent
Anthropic · bitcoin preference rate68 percent
Elf Labs · trademarks copyrights owned500 assets
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
Al Thinks Bitcoin Is the Money of the Future – New Study Says It's the Top Pick — Source | Via News | ViaNews EU